Table 2.
Ep-CAM expression | |||||
Variable | Patients | 0 | 1+ | 2+ | 3+ |
Patients | 10 | 15 | 7 | 21 | |
Male | 39 (74) | 8 (80) | 10 (67) | 4 (57) | 17 (81) |
Female | 14 (26) | 2 (20) | 5 (33) | 3 (43) | 4 (19) |
Primary Tumor | |||||
pT1 | 15 (28) | 4 (40) | 3 (20) | 3 (42) | 5 (24) |
pT2 | 8 (15) | 1 (10) | 2 (13) | 2 (29) | 3 (14) |
pT3 | 30 (57) | 5 (50) | 10 (67) | 2 (29) | 13 (62) |
Lymph node status | |||||
pN0 | 27 (51) | 4 (40) | 9 (60) | 5 (71) | 9 (43) |
pN1 | 26 (49) | 6 (60) | 6 (40) | 2 (29) | 12 (57) |
Tumor grade | |||||
G2 | 38 (72) | 7 (70) | 11 (73) | 5 (71) | 15 (71) |
G3 | 15 (28) | 3 (30) | 4 (27) | 2 (29) | 6 (29) |
*No statistical significant correlations between Ep-CAM expression and histopathological parameters were observed.